[1]
Shakhnoza , I. and Qamardinovna , D. trans. 2026. Effect of SGLT-2 inhibitors on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and MASLD. Uzbekistan Open Conference. 1 (May 2026). DOI:https://doi.org/10.57033/RSSPMCE-2026-00022.